ES525013A0 - Un procedimiento para preparar compuestos de espiro (2h-1,4-benzodioxepin-3(5h)4'-piperidina y -3'-pirrolidina) - Google Patents

Un procedimiento para preparar compuestos de espiro (2h-1,4-benzodioxepin-3(5h)4'-piperidina y -3'-pirrolidina)

Info

Publication number
ES525013A0
ES525013A0 ES525013A ES525013A ES525013A0 ES 525013 A0 ES525013 A0 ES 525013A0 ES 525013 A ES525013 A ES 525013A ES 525013 A ES525013 A ES 525013A ES 525013 A0 ES525013 A0 ES 525013A0
Authority
ES
Spain
Prior art keywords
compounds
benzodioxepin
piperidine
pirrolidine
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES525013A
Other languages
English (en)
Other versions
ES8505685A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Roussel Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharmaceuticals Inc filed Critical Hoechst Roussel Pharmaceuticals Inc
Publication of ES8505685A1 publication Critical patent/ES8505685A1/es
Publication of ES525013A0 publication Critical patent/ES525013A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02—Seven-membered rings
    • C07D321/10—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/113—Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES525013A 1982-08-20 1983-08-18 Un procedimiento para preparar compuestos de espiro (2h-1,4-benzodioxepin-3(5h)4'-piperidina y -3'-pirrolidina) Granted ES525013A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/410,155 US4405631A (en) 1982-08-20 1982-08-20 Spiro[2H-1,4-benzodioxepin-3(5H)4'-piperidine and -3'pyrrolidine] compounds and their use as antihypertensive agents

Publications (2)

Publication Number Publication Date
ES8505685A1 ES8505685A1 (es) 1985-06-01
ES525013A0 true ES525013A0 (es) 1985-06-01

Family

ID=23623465

Family Applications (2)

Application Number Title Priority Date Filing Date
ES525013A Granted ES525013A0 (es) 1982-08-20 1983-08-18 Un procedimiento para preparar compuestos de espiro (2h-1,4-benzodioxepin-3(5h)4'-piperidina y -3'-pirrolidina)
ES540841A Granted ES540841A0 (es) 1982-08-20 1985-03-01 Un procedimiento compuesto de espiro 2h-1,4-benzodioxepin-3 (5h)4'-piperidina y -3'-pirrolidina

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES540841A Granted ES540841A0 (es) 1982-08-20 1985-03-01 Un procedimiento compuesto de espiro 2h-1,4-benzodioxepin-3 (5h)4'-piperidina y -3'-pirrolidina

Country Status (20)

Country Link
US (1) US4405631A (es)
EP (1) EP0102034B1 (es)
JP (1) JPS5953489A (es)
KR (1) KR840005729A (es)
AT (1) ATE33656T1 (es)
AU (1) AU576473B2 (es)
CA (1) CA1210764A (es)
DE (1) DE3376327D1 (es)
DK (1) DK381983A (es)
ES (2) ES525013A0 (es)
FI (1) FI832959A (es)
GR (1) GR78667B (es)
HU (1) HU191874B (es)
IL (1) IL69525A0 (es)
MA (1) MA19881A1 (es)
NO (1) NO833001L (es)
NZ (1) NZ205320A (es)
PH (1) PH18839A (es)
PT (1) PT77223B (es)
ZA (1) ZA836127B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4521537A (en) * 1982-08-20 1985-06-04 Hoechst-Roussel Pharmaceuticals Incorporated Spiro[2H-1,4-benzodioxepin-3(5H)4'-piperidine and -3'-pyrrolidine] compounds and their use as antihypertensive agents
US4472580A (en) * 1982-08-20 1984-09-18 Hoechst-Roussel Pharmaceuticals Incorporated Spiro (2H-1,4-benzodioxepin-3 (5H)4-piperidine and -3-pyrrolidine) compounds and their use as anti-hypertensive agents
US4751223A (en) * 1986-10-14 1988-06-14 Hoechst-Roussel Pharmaceuticals, Inc. Antiinflammatory and analgesic aminoalkyl tetracyclic benzodiazepines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1312894A (fr) * 1962-01-29 1962-12-21 Geigy Ag J R Nouveaux composés hétérocycliques à 2 atomes d'oxygène dans le cycle et leur préparation
CH469736A (de) * 1966-06-28 1969-03-15 Geigy Ag J R Verfahren zur Herstellung von neuen Heterospiroalkanen
US3679666A (en) * 1969-04-03 1972-07-25 Hoffmann La Roche 4-(4-hydroxypiperidino)-4'-fluorobutyrophenones

Also Published As

Publication number Publication date
AU576473B2 (en) 1988-09-01
IL69525A0 (en) 1983-11-30
PT77223B (en) 1986-03-18
MA19881A1 (fr) 1984-04-01
DK381983A (da) 1984-02-21
EP0102034A1 (en) 1984-03-07
ES8505685A1 (es) 1985-06-01
NO833001L (no) 1984-02-21
AU1816983A (en) 1984-02-23
KR840005729A (ko) 1984-11-16
PH18839A (en) 1985-10-10
CA1210764A (en) 1986-09-02
EP0102034B1 (en) 1988-04-20
FI832959A (fi) 1984-02-21
ES8602800A1 (es) 1985-12-01
FI832959A0 (fi) 1983-08-18
DE3376327D1 (en) 1988-05-26
ES540841A0 (es) 1985-12-01
JPS5953489A (ja) 1984-03-28
HU191874B (en) 1987-04-28
DK381983D0 (da) 1983-08-19
ZA836127B (en) 1984-04-25
NZ205320A (en) 1987-05-29
GR78667B (es) 1984-09-27
ATE33656T1 (de) 1988-05-15
US4405631A (en) 1983-09-20
PT77223A (en) 1983-09-01

Similar Documents

Publication Publication Date Title
IL127244A (en) Substituted amines, methods of their preparation and pharmaceutical compositions containing them
ES8802386A1 (es) Procedimiento para prepara (1,2,4)-triazolo (1,5-c)quinazolinas
EA200000592A1 (ru) Азаполициклические соединения, конденсированные с арилом
ES8706132A1 (es) Un procedimiento para la preparacion de analogos de benzodiazepina
PT85651A (en) Compounds
HU9603228D0 (en) Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
IL111365A0 (en) (r)-5-carbamoyl -8-fluoro-3-n, n-disubstituted-amino-3, 4-dihydro-2h-1- benzopyrans
ES8601965A1 (es) Un procedimiento para la preparacion de una nueva serie de derivados de (1-piperidinilalquil)pirimidinona
MY102038A (en) 4-substituted androstendione derivatives and process for their preparation
YU211087A (en) Process for obtaining new n-substituted benzimidazolic derivatives
EP0229444A3 (en) Medicaments for the treatment of anxiety
IL76456A0 (en) 1-substituted tetralin derivatives,their preparation and pharmaceutical compositions containing them
ES8601915A1 (es) Un procedimiento para preparar derivados de piridazinona
ZA879280B (en) Basically substituted phenylacetonitriles,their preparation and drugs containing these compounds
ES525013A0 (es) Un procedimiento para preparar compuestos de espiro (2h-1,4-benzodioxepin-3(5h)4'-piperidina y -3'-pirrolidina)
GB2209281B (en) Pharmaceutical compositions comprising an alpha-2 adrenoceptor antagonist
DE3374005D1 (en) 1-methyl-5-nitro-imidazoline derivatives and therapeutic compositions which contain them as active principle
ES550742A0 (es) Un procedimiento para la preparacion de una octahidroindo- lizina
EP0418064A3 (en) Naphthalene and tetrahydronaphthalene gem-diphosphonate derivatives